Results 151 to 160 of about 39,703 (307)

Survey of quality control testing practices on low titer group O whole blood in the United States

Transfusion, EarlyView.
Abstract Background Use of low titer group O whole blood (LTOWB) continues to increase in the United States (US). This survey sampled the quality control (QC) practices among the largest blood collectors in the US. Methods A survey on LTOWB collection, QC testing, and distribution was developed and electronically distributed to the chief medical ...
Mark H. Yazer, Skye Clayton, Christine M. Leeper, Philip C. Spinella   +3 more
wiley   +1 more source

Early transfusion strategies in haemorrhagic shock. [PDF]

Scand J Trauma Resusc Emerg Med
Rognes IN, Rehn M.
europepmc   +1 more source

Early exposure, enduring consequences: How do I manage Rh immunoglobulin prophylaxis after Rh‐mismatched transfusions in children?

Transfusion, EarlyView.
Abstract Background RhD mismatched transfusions in RhD negative women have the potential to impact future pregnancies through alloimmunization and development of hemolytic disease of the fetus and newborn (HDFN). As use of RhD positive emergency‐release blood products in pediatric trauma has increased, it has become clear that a significant ...
Kirea Lange, Alexander Bowers, Niruktha Raghavan, Hannah Borland, Leslie Greebon, Christine Leeper, Barbara Gaines, Donald Jenkins   +7 more
wiley   +1 more source

Pathogen‐reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange

Transfusion, EarlyView.
Abstract Background Therapeutic plasma exchange (TPE) for thrombotic thrombocytopenic purpura (TTP) and auto‐immune disorders involves repeated patient exposure to allogenic plasma with the risk of transfusion‐transmitted infection (TTI).
Florian Tupin, Clarisse Mouriaux, Beatrice Hechler, Kaja Kaastrup, Subra Yegneswaran, Laurence Corash, Pierre H. Mangin   +6 more
wiley   +1 more source

Anastomotic leakage after rectosigmoid resection with primary anastomosis during cytoreductive surgery for advanced high-grade serous ovarian cancer: risk factors and oncologic outcomes. [PDF]

J Ovarian Res
Tasci AE, Kılıç F, Ünsal M, Aytekin O, Özkaya Uçar Y, Tiryaki Güner G, Ersak B, Buran A, Canbulut İE, Çakır C, Koç S, Boran N, Moraloğlu Tekin Ö, Üstün Y, Turan AT.   +14 more
europepmc   +1 more source

Automated cell count for blood component quality control

Transfusion, EarlyView.
Abstract Background Accurate quantification of residual leukocytes (rWBC) and red blood cells (rRBC) in leukoreduced blood components is essential to ensure product quality and transfusion safety. Conventional manual flow cytometry techniques are time‐consuming and analyst‐dependent.
Gemma Aran, Silvia Torrents, Margarita Blanco, Nicole Somarriba, F. Javier Algar, Fatima Shettiyar, Laura Galvez, Sara Lopez, Begoña Amill, Mireia Lloret, Sergi Torramade‐Moix, Núria Martinez‐Llonch, Glòria Soria, Margarita Codinach   +13 more
wiley   +1 more source

When HbA1c looks "too high": two practical clarifications for endocrine screening in chelated β-thalassemia major. [PDF]

Ther Adv Endocrinol Metab
Wen A.
europepmc   +1 more source

Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage [PDF]

, 2018
Doctor, Allan, et al.,, Rogers, Stephen C   +2 more
core   +1 more source

Pediatric autologous peripheral blood stem cell collection without heparin using a highly concentrated sodium citrate anticoagulant: A retrospective comparison with standard ACD‐A

Transfusion, EarlyView.
Abstract Background Heparin combined with sodium citrate has been used in leukocytapheresis for pediatric patients. Since 2022, we have performed leukocytapheresis using a highly concentrated sodium citrate solution (HSC, 5.32%) instead of acid citrate dextrose solution A (ACD‐A).
Keiko Fujii, Wataru Kitamura, Kana Washio, Kazuhiro Ikeuchi, Joji Shimono, Hiroyuki Murakami, Fumio Otsuka, Yoshinobu Maeda, Nobuharu Fujii   +8 more
wiley   +1 more source

Transfusion strategies in thalassemia and sickle cell disease SITE-SIMTI-SIdEM Good Practice. [PDF]

Blood Transfus
Forni GL, Vassanelli A, De Franceschi L, Marson P, Lisi R, Ostuni A, Gigante A, Origa R, Fiorin F.   +8 more
europepmc   +1 more source